Here are three things to know:
1. The surgery was performed through OrthoPediatrics’ exclusive agreement with Tokyo-based Robert Reid, a company that imports and distributes surgical products from the U.S. and Europe and manufactures orthopedic surgical products.
2. The Response system is designed to treat pediatric spinal deformity and is intended system is intended for immobilization and stabilization of the posterior non-cervical spine.
3. OrthoPediatrics focuses exclusively on pediatric orthopedics and distributes its products in the U.S. and 38 other countries. This case represents OrthoPediatrics’ expansion into the Japanese market.
More articles on devices:
Spinal implants market to experience 5.5% CAGR through 2023: 3 observations
How Mizuho OSI® will stay on the forefront of orthopedic innovation
